Avoro Capital Advisors LLC

Holdings History for Whitehawk Therapeutics, Inc. - Common stock (WHWK)

Symbol: WHWK on Nasdaq
Investment type: Equity / Common stock
Latest Disclosed Shares Owned: 11,914,961 shares
Security Ownership %: 20%

Shares, Excluding Options vs Price

Value, Excluding Options

BEHZAD AGHAZADEH ownership in Whitehawk Therapeutics, Inc. Common stock (WHWK)

04 Mar 2025 - BEHZAD AGHAZADEH has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 11,914,961 shares of Whitehawk Therapeutics, Inc. Common stock (WHWK). This represents 20% ownership of the company. In their previous filing dated 23 Dec 2024, Avoro Capital Advisors LLC had reported owning 3,581,961 shares, indicating an increase of +233%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
BEHZAD AGHAZADEH	20%	+37%	$18,349,040	11,914,961	+8,333,000	+233%	$1.54	13D/A	28 Feb 2025	04 Mar 2025, 17:58
BEHZAD AGHAZADEH	14%		$5,516,220	3,581,961			$1.54	13D/A	19 Dec 2024	23 Dec 2024, 15:51

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.07%	0%	$6,895,553	2,849,402	0		$2.42	Q4 2025
30 Sep 2025	0.07%	0%	$5,413,864	2,849,402	0		$1.90	Q3 2025
30 Jun 2025	0.09%	0%	$5,328,382	2,849,402	0		$1.87	Q2 2025
31 Mar 2025	0.08%	0%	$5,071,936	2,849,402	0		$1.78	Q1 2025
31 Dec 2024	0.13%	0%	$8,989,863	2,849,402	0		$3.15	Q4 2024
30 Sep 2024	0.09%	0%	$5,869,768	2,849,402	0		$2.06	Q3 2024
30 Jun 2024	0.06%	0%	$4,160,127	2,849,402	0		$1.46	Q2 2024
31 Mar 2024	0.08%	0%	$6,667,601	2,849,402	0		$2.34	Q1 2024
31 Dec 2023	0.08%	0%	$5,755,792	2,849,402	0		$2.02	Q4 2023
30 Sep 2023	0.22%	0%	$13,791,106	2,849,402	0		$4.84	Q3 2023
30 Jun 2023	0.26%	0%	$19,489,910	2,849,402	0		$6.84	Q2 2023
31 Mar 2023	0.31%	0%	$20,629,670	2,849,402	0		$7.24	Q1 2023
31 Dec 2022	0.55%	0%	$36,557,828	2,849,402	0		$12.83	Q4 2022
30 Sep 2022	0.74%	+0.27%	$40,262,000	2,849,402	+1,020,000	+56%	$14.13	Q3 2022
30 Jun 2022	0.45%	0%	$22,538,000	1,829,402	0		$12.32	Q2 2022
31 Mar 2022	0.57%	0%	$31,045,000	1,829,402	0		$16.97	Q1 2022
31 Dec 2021	0.75%	0%	$44,180,000	1,829,402	0		$24.15	Q4 2021
30 Sep 2021	0.85%	+0.85%	$53,730,000	1,829,402	+1,829,402	NEW	$29.37	Q3 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.